MICROBIOTIX, INC.
Federal contract awards won by MICROBIOTIX, INC. (UEI SCNKBDM341T1), 2017–2022 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
3
awards
$18,653,501
total value
2
agencies
Agencies buying from MICROBIOTIX, INC.
What MICROBIOTIX, INC. sells
Awards
TO DEVELOP THE PPZ SERIES OF SMALL MOLECULE PAN-FILOVIRUS ENTRY INHIBITORS THROUGH LEAD OPTIMIZATION, SELECTION OF A PRECLINICAL CANDIDATE, AND IND-ENABLING PRECLINICAL STUDIES.
Department of Health and Human Services · $8,795,790 · Nov 1, 2022
TO DEVELOP PHENOXYACETAMIDE T3SS INHIBITORS AS ADJUNCTIVE AGENTS TO ANTIBACTERIAL THERAPY FOR MDR P. AERUGINOSA INFECTIONS.
Department of Health and Human Services · $7,263,391 · Jul 1, 2020
DEVELOP NOVEL AND INNOVATIVE SMALL MOLECULE THERAPEUTICS TO TREAT (POST-EXPOSURE THERAPEUTIC) INFECTIONS BY BOTH FILOVIRUS FAMILY MEMBERS (EBOLA VIRUSES AND MARBURG VIRUSES)
Department of Defense · $2,594,320 · Dec 15, 2017
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids